Literature DB >> 28447284

Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis.

Axel Van Der Gucht1,2, Anne-Ségolène Cottereau3,4, Mukedaisi Abulizi3,4, Aziz Guellich3,5,6,7, Paul Blanc-Durand3,4, Jean-Marc Israel3,4, Arnault Galat3,5,6,7, Violaine Plante-Bordeneuve3,5,7,8, Jean-Luc Dubois-Randé3,5,6,7, Diane Bodez3,5,6,7, Jean Rosso3,4,5, Thibaud Damy3,5,6,7, Emmanuel Itti3,4,5,7.   

Abstract

BACKGROUND: A decreased longitudinal strain in basal segments with a base-to-apex gradient has been described in patients with cardiac amyloidosis (CA).
OBJECTIVES: Aim was to investigate the left ventricular (LV) regional distribution of early-phase 99mTc-Hydroxymethylene diphosphonate (99mTc-HMDP) uptake in patients with transthyretin-related cardiac amyloidosis (TTR-CA).
METHODS: All patients underwent a whole-body planar 99mTc-HMDP scintigraphy acquired at 10-min post-injection (early-phase) followed by a thorax SPECT/CT. The segmental uptake (expressed as % of maximal myocardial HMDP uptake) was investigated on the AHA 17-segment model and 3-segment model (basal, mid-cavity, apical).
RESULTS: Sixty-one TTR-CA patients were included of whom 29 were wild-type (wt-TTR-CA) and 32 had hereditary TTR-CA (m-TTR-CA). Early myocardial 99mTc-HMDP uptake occurred in all TTR-CA. In all patients, segmental analysis of the LV myocardial distribution of 99mTc-HMDP uptake showed an increased median uptake (interquartile range) in basal/mid-cavity segments compared to the lowest median uptake of apical segments (respectively, 79% [72%-86%] vs. 72% [64%-81%]; P < 10-6). This pattern was similar in wt-TTR-CA group (78% [70%-84%] vs. 70% [61%-81%]; P < 10-6), in m-TTR-CA group (80% [74%-86%] vs. 73 [66%-82%]; P < 10-7) and remained constant independently of the TTR mutation subtype with P ranging 10-5 to 0.03.
CONCLUSIONS: Early-phase myocardial scintigraphy identified regional distribution of 99mTc-HMDP uptake characterized by a base-to-apex gradient, corroborating echocardiographic, and cardiac magnetic resonance findings. This apical sparing pattern was similar across TTR-CA and TTR mutation subtypes.

Entities:  

Keywords:  HMDP; SPECT/CT; apical sparing; cardiac amyloidosis; protein deposition; transthyretin

Mesh:

Substances:

Year:  2017        PMID: 28447284     DOI: 10.1007/s12350-017-0894-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

1.  Uptake of technetium 99m HDP in cardiac amyloidosis.

Authors:  Jan Kulhanek; Assad Movahed
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

2.  Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?

Authors:  Arnault Galat; Aziz Guellich; Diane Bodez; Michel Slama; Marina Dijos; David Messika Zeitoun; Olivier Milleron; David Attias; Jean-Luc Dubois-Randé; Dania Mohty; Etienne Audureau; Emmanuel Teiger; Jean Rosso; Jean-Luc Monin; Thibaud Damy
Journal:  Eur Heart J       Date:  2016-02-22       Impact factor: 29.983

3.  Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.

Authors:  Arnault Galat; Jean Rosso; Aziz Guellich; Axel Van Der Gucht; Stephane Rappeneau; Diane Bodez; Soulef Guendouz; Claire-Marie Tissot; Luc Hittinger; Jean-Luc Dubois-Randé; Violaine Plante-Bordeneuve; Emmanuel Itti; Michel Meignan; Thibaud Damy
Journal:  Amyloid       Date:  2015-10-14       Impact factor: 7.141

4.  Simultaneous transmission-emission thallium-201 cardiac SPECT: effect of attenuation correction on myocardial tracer distribution.

Authors:  E P Ficaro; J A Fessler; R J Ackermann; W L Rogers; J R Corbett; M Schwaiger
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

5.  Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.

Authors:  D F Worsley; B C Lentle
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

6.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

7.  A new algorithm for the quantitation of myocardial perfusion SPECT. II: validation and diagnostic yield.

Authors:  T Sharir; G Germano; P B Waechter; P B Kavanagh; J S Areeda; J Gerlach; X Kang; H C Lewin; D S Berman
Journal:  J Nucl Med       Date:  2000-04       Impact factor: 10.057

8.  Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study.

Authors:  Jean-François Deux; Thibaud Damy; Alain Rahmouni; Julie Mayer; Violaine Planté-Bordeneuve
Journal:  Amyloid       Date:  2014-09-11       Impact factor: 7.141

9.  Native T1 mapping in transthyretin amyloidosis.

Authors:  Marianna Fontana; Sanjay M Banypersad; Thomas A Treibel; Viviana Maestrini; Daniel M Sado; Steven K White; Silvia Pica; Silvia Castelletti; Stefan K Piechnik; Matthew D Robson; Janet A Gilbertson; Dorota Rowczenio; David F Hutt; Helen J Lachmann; Ashutosh D Wechalekar; Carol J Whelan; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

View more
  9 in total

1.  Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis.

Authors:  Sarah Pradel; Stéphanie Brun; Gérard Victor; Pierre Pascal; Pauline Fournier; David Ribes; Yoan Lavie-Badie; Michel Galinier; Didier Carrié; Isabelle Berry; Olivier Lairez
Journal:  J Nucl Cardiol       Date:  2018-06-07       Impact factor: 5.952

2.  Cardiac amyloidosis: A new challenge of multimodality imaging.

Authors:  Carmela Nappi; Roberta Assante; Emilia Zampella; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-06-26       Impact factor: 5.952

3.  Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.

Authors:  Giorgio Treglia; Andor W J M Glaudemans; Francesco Bertagna; Bouke P C Hazenberg; Paola A Erba; Raffaele Giubbini; Luca Ceriani; John O Prior; Luca Giovanella; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-23       Impact factor: 9.236

4.  Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis.

Authors:  Claudio Rapezzi; Christian Gagliardi; Agnese Milandri
Journal:  J Nucl Cardiol       Date:  2018-02-22       Impact factor: 5.952

5.  Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis.

Authors:  Alain Manrique; David Dudoignon; Stéphanie Brun; Catherine N'Ganoa; Emmanuelle Cassol; Damien Legallois; Yoan Lavie-Badie; Denis Agostini; Olivier Lairez
Journal:  EJNMMI Res       Date:  2019-12-23       Impact factor: 3.138

6.  Base-to-apex gradient pattern of cardiac impairment identified on myocardial T1 mapping in cardiac amyloidosis.

Authors:  Seitaro Oda; Yawara Kawano; Yutaka Okuno; Daisuke Utsunomiya; Takeshi Nakaura; Kenichi Tsujita; Yasuyuki Yamashita
Journal:  Radiol Case Rep       Date:  2018-10-18

Review 7.  Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis.

Authors:  Ali M Agha; Purvi Parwani; Avirup Guha; Jean B Durand; Cezar A Iliescu; Saamir Hassan; Nicolas L Palaskas; Greg Gladish; Peter Y Kim; Juan Lopez-Mattei
Journal:  Open Heart       Date:  2018-09-26

Review 8.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30

Review 9.  Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.

Authors:  Grigorios Korosoglou; Sorin Giusca; Florian André; Fabian Aus dem Siepen; Peter Nunninger; Arnt V Kristen; Norbert Frey
Journal:  Vasc Health Risk Manag       Date:  2021-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.